{"disease":{"id":"eye-disease","name":"eye disease"},"drugs":{"marketed":[{"drug_id":"teprotumumab","indication_name":"Thyroid eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tepezza","generic_name":"TEPROTUMUMAB","company_name":"Horizon Therapeutics Ireland","drug_phase":"marketed","molecular_target":"IGF-1R","drug_class":"Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]","quality_score":10,"revenue":"2000","mechanism":"Teprotumumab-trbw binds to IGF-1R and blocks its activation and signaling."},{"drug_id":"teprotumumab","indication_name":"Thyroid Eye Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tepezza","generic_name":"TEPROTUMUMAB","company_name":"Horizon Therapeutics Ireland","drug_phase":"marketed","molecular_target":"IGF-1R","drug_class":"Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]","quality_score":10,"revenue":"2000","mechanism":"Teprotumumab-trbw binds to IGF-1R and blocks its activation and signaling."},{"drug_id":"perfluorohexyloctane","indication_name":"Dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miebo","generic_name":"PERFLUOROHEXYLOCTANE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Semifluorinated Alkane [EPC]","quality_score":44,"revenue":null,"mechanism":"Miebo works by mimicking the natural oils in the eyes to help maintain moisture."},{"drug_id":"acoltremon","indication_name":"dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tryptyr","generic_name":"ACOLTREMON","company_name":"Alcon Labs Inc","drug_phase":"marketed","molecular_target":"","drug_class":"TRPM8 Thermoreceptor Agonist [EPC]","quality_score":41,"revenue":null,"mechanism":"Tryptyr works by modulating the function of the lacrimal gland to increase tear production."},{"drug_id":"acoltremon","indication_name":"dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tryptyr","generic_name":"ACOLTREMON","company_name":"Alcon Labs Inc","drug_phase":"marketed","molecular_target":"","drug_class":"TRPM8 Thermoreceptor Agonist [EPC]","quality_score":41,"revenue":null,"mechanism":"Tryptyr works by modulating the function of the lacrimal gland to increase tear production."},{"drug_id":"teprotumumab-trbw","indication_name":"Thyroid eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"TEPEZZA","generic_name":"TEPROTUMUMAB-TRBW","company_name":"HORIZON THERAPEUTICS IRELAND","drug_phase":"marketed","molecular_target":"Insulin-like growth factor 1 receptor","drug_class":"Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"perfluorohexyloctane","indication_name":"Dry Eye Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miebo","generic_name":"PERFLUOROHEXYLOCTANE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Semifluorinated Alkane [EPC]","quality_score":44,"revenue":null,"mechanism":"Miebo works by mimicking the natural oils in the eyes to help maintain moisture."},{"drug_id":"miebo","indication_name":"Dry eye disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Miebo","company_name":"Bausch & Lomb Incorporated","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl160","indication_name":"Dry Eye Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CYCLOSPORINE","company_name":"","drug_phase":"marketed","molecular_target":"calcineurin","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":35,"revenue":null,"mechanism":"Cyclosporine, a calcineurin inhibitor, selectively modulates the immune system."}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04053335","title":"Smarter Care Virginia, Examining Low-Value Care in Virginia","phase":"","overall_status":"COMPLETED","enrollment_count":5000000,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT03579797","title":"Shanghai Diabetic Eye Study in Diabetics","phase":"","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"Shanghai Eye Disease Prevention and Treatment Center","has_results":false},{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT00655096","title":"Screening for Research Participants","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05930444","title":"Multimodal Machine Learning for Auxiliary Diagnosis of Eye Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":9825,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT06812845","title":"Patterns of Eye Diseases Among Patients Attending The Eye Investigation Unit of Sohag University Hospital","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT00342810","title":"Analyses of Existing Framingham Data","phase":"","overall_status":"COMPLETED","enrollment_count":6061,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT03753893","title":"Ocular Manifestations in Rheumatic Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT02771236","title":"Clinical and Molecular Studies in Families With Inherited Eye Disease","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04763785","title":"Development of a Keratoconus Detection Algorithm by Deep Learning Analysis and Its Validation on Eyestar Images","phase":"","overall_status":"UNKNOWN","enrollment_count":4800,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT06605495","title":"Using Dry Eye As a Disease Model, Investigators Demonstrated the Optimal Selection of Individualized Clinical Interventions and the Superiority of Dynamic Treatment Discrimination in Chinese Medicine.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Xuejing Lu","has_results":false},{"nct_id":"NCT05851287","title":"The Aging Eye Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT04149210","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2410,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":true},{"nct_id":"NCT03029104","title":"Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2228,"lead_sponsor_name":"Cxlusa","has_results":true},{"nct_id":"NCT00708955","title":"Evaluation and Treatment of People With Eye Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":2164,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT07457021","title":"A Study to Evaluate the Safety and Effectiveness of Perfluorohexyloctane Eye Drops on Treatment of Dry Eye Disease (DED) Related to Meibomian Gland Dysfunction (MGD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Xiamen Ophthalmology Center Affiliated to Xiamen University","has_results":false},{"nct_id":"NCT07154680","title":"Ophthalmic Diseases and AI: an RCT Study","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"North Sichuan Medical College","has_results":false},{"nct_id":"NCT02077894","title":"Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04497207","title":"Deep Learning for Classification of Scheimpflug Corneal Tomography Images","phase":"","overall_status":"COMPLETED","enrollment_count":1669,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06213896","title":"Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images","phase":"","overall_status":"COMPLETED","enrollment_count":1528,"lead_sponsor_name":"Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi","has_results":false},{"nct_id":"NCT04800718","title":"Increasing Vision Center Service Utilization","phase":"NA","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Seva Foundation","has_results":false},{"nct_id":"NCT02471287","title":"Genetics of Inherited Eye Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT03899922","title":"Monitoring Drug-induced Uveitis","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT07322302","title":"RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT02317328","title":"Adaptive Optics Retinal Imaging","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT02821767","title":"Natural History, Pathogenesis, and Outcome of Ocular Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06018571","title":"Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US","phase":"","overall_status":"COMPLETED","enrollment_count":946,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04582253","title":"Pix2pix Networks for Scheimpflug Corneal Tomography Image Generation","phase":"","overall_status":"COMPLETED","enrollment_count":923,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04523129","title":"ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":834,"lead_sponsor_name":"Novaliq GmbH","has_results":true},{"nct_id":"NCT06047418","title":"Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":823,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT06879782","title":"Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":820,"lead_sponsor_name":"Lunan Better Pharmaceutical Co., LTD.","has_results":false},{"nct_id":"NCT04302220","title":"Myopic Optic Neuropathy in Chinese High Myopia Population","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":813,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT00001732","title":"Screening for Studies on Inherited Eye Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04036292","title":"Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":758,"lead_sponsor_name":"Oyster Point Pharma, Inc.","has_results":true},{"nct_id":"NCT04735393","title":"A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":757,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true},{"nct_id":"NCT04271709","title":"Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":749,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT05695781","title":"Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":740,"lead_sponsor_name":"BRIM Biotechnology Inc.","has_results":false},{"nct_id":"NCT04426331","title":"Vouchers to Increase Uptake of Already Free Eye Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":739,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT01743729","title":"A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT02284516","title":"A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":711,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT05105620","title":"Deep Learning for Fluorescein Angiography and Optical Coherence Tomography Macular Thickness Map Image Translation","phase":"","overall_status":"COMPLETED","enrollment_count":708,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05403827","title":"A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":true},{"nct_id":"NCT05848128","title":"Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":642,"lead_sponsor_name":"Mimetogen Pharmaceuticals USA, Inc.","has_results":false},{"nct_id":"NCT03652415","title":"DRy Eye Outcome and Prescription Study","phase":"","overall_status":"UNKNOWN","enrollment_count":635,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT05158699","title":"Effectiveness of Periocular Drug Injection in CATaract Surgery","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":628,"lead_sponsor_name":"Luigi Rondas","has_results":false},{"nct_id":"NCT04931186","title":"Nasolacrimal Duct Obstruction","phase":"","overall_status":"COMPLETED","enrollment_count":625,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04567329","title":"Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":620,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT03587948","title":"Shanghai Children and Adolescent Diabetes Eye Study","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Shanghai Eye Disease Prevention and Treatment Center","has_results":false},{"nct_id":"NCT04658238","title":"Ocular Microbiome and Immune System in Dry Eyes","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT00088348","title":"Screening for Research Subjects With Anterior Segment Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}